Taysha Gene Therapies Inc
NASDAQ:TSHA
Taysha Gene Therapies Inc
NASDAQ:TSHA
Price:
4.57
USD
-2.14%
Market Closed
Market Cap:
$1.3B
Cash Flow Statement
Cash Flow Statement
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
Currency: USD
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(92)
|
(106)
|
(142)
|
(175)
|
(193)
|
(186)
|
(161)
|
(166)
|
(133)
|
(124)
|
(214)
|
(112)
|
(118)
|
(114)
|
(23)
|
(89)
|
(87)
|
(93)
|
(100)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
7
|
11
|
17
|
18
|
20
|
20
|
19
|
18
|
14
|
12
|
10
|
8
|
9
|
11
|
12
|
13
|
13
|
13
|
13
|
|
| Other Non-Cash Items |
38
|
23
|
25
|
28
|
26
|
26
|
24
|
57
|
52
|
53
|
154
|
54
|
56
|
53
|
(44)
|
18
|
18
|
19
|
14
|
|
| Cash Interest Paid |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Change in Working Capital |
1
|
12
|
20
|
29
|
30
|
13
|
(7)
|
20
|
13
|
16
|
16
|
(17)
|
(12)
|
(15)
|
(14)
|
(11)
|
(16)
|
(10)
|
0
|
|
| Cash from Operating Activities |
(53)
N/A
|
(71)
-35%
|
(97)
-35%
|
(117)
-21%
|
(136)
-16%
|
(146)
-8%
|
(143)
+2%
|
(88)
+38%
|
(68)
+23%
|
(53)
+22%
|
(42)
+20%
|
(73)
-73%
|
(73)
+1%
|
(75)
-4%
|
(79)
-5%
|
(81)
-3%
|
(83)
-3%
|
(82)
+2%
|
(85)
-3%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(1)
|
(4)
|
(7)
|
(15)
|
(23)
|
(28)
|
(27)
|
(21)
|
(16)
|
(8)
|
(6)
|
(4)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
|
| Other Items |
0
|
(12)
|
(12)
|
(6)
|
(9)
|
(4)
|
(5)
|
(4)
|
(1)
|
(1)
|
(4)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(10)
N/A
|
(15)
-57%
|
(19)
-26%
|
(22)
-13%
|
(32)
-51%
|
(32)
+1%
|
(31)
+3%
|
(25)
+20%
|
(17)
+30%
|
(9)
+47%
|
(10)
-5%
|
(7)
+24%
|
(4)
+51%
|
(4)
-7%
|
(0)
+90%
|
(0)
+6%
|
(1)
-64%
|
(0)
+44%
|
(0)
-4%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
291
|
272
|
(1)
|
0
|
0
|
12
|
12
|
42
|
42
|
30
|
171
|
141
|
141
|
211
|
77
|
77
|
77
|
223
|
216
|
|
| Net Issuance of Debt |
0
|
(0)
|
30
|
40
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| Other |
0
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
10
|
10
|
11
|
11
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
291
N/A
|
273
-6%
|
28
-90%
|
39
+37%
|
39
0%
|
50
+28%
|
20
-60%
|
52
+161%
|
52
0%
|
41
-21%
|
182
+342%
|
136
-25%
|
137
+0%
|
207
+51%
|
73
-65%
|
77
+5%
|
77
0%
|
222
+190%
|
225
+1%
|
|
| Change in Cash | ||||||||||||||||||||
| Net Change in Cash |
229
N/A
|
186
-19%
|
(87)
N/A
|
(100)
-14%
|
(129)
-30%
|
(128)
+1%
|
(154)
-20%
|
(61)
+60%
|
(33)
+46%
|
(21)
+36%
|
130
N/A
|
56
-57%
|
61
+8%
|
128
+111%
|
(7)
N/A
|
(5)
+26%
|
(7)
-51%
|
140
N/A
|
140
0%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(53)
N/A
|
(75)
-41%
|
(104)
-38%
|
(132)
-28%
|
(159)
-20%
|
(175)
-10%
|
(170)
+3%
|
(109)
+36%
|
(84)
+23%
|
(61)
+27%
|
(48)
+21%
|
(77)
-59%
|
(73)
+5%
|
(76)
-4%
|
(79)
-5%
|
(82)
-3%
|
(84)
-3%
|
(83)
+2%
|
(85)
-3%
|
|
Switch to:
Switch to:
See Also
Discover More
